Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone fragment ACTH(4-10) with a Pro-Gly-Pro C-terminal extension. PX1 Research provides research-grade Semax synthesized in USA-based GMP-compliant facilities, verified by lot-specific HPLC and Mass Spectrometry analysis for rigorous in vitro and preclinical research applications.
Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone fragment ACTH(4-10) with a Pro-Gly-Pro C-terminal extension. PX1 Research provides research-grade Semax synthesized in USA-based GMP-compliant facilities, verified by lot-specific HPLC and Mass Spectrometry analysis for rigorous in vitro and preclinical research applications.
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analogue of the adrenocorticotropic hormone sequence ACTH(4-10), modified with a tripeptide Pro-Gly-Pro tail at the C-terminus. This structural modification was engineered to enhance metabolic stability against circulating proteases and peptidases, significantly extending the terminal half-life of the peptide in aqueous solution and biological assay media compared to the native sequence.
When principal investigators evaluate where to buy Semax, chemical structural integrity is a foundational priority. Semax possesses a molecular formula of C37H51N9O10S and a precise molecular mass of 813.92 g/mol. The incorporation of the C-terminal tripeptide proline-glycine-proline preserves the peptide's spatial conformation, allowing researchers to study stable ligand-receptor dynamics without rapid enzymatic degradation interrupting experimental timelines.
As a core compound in neurobiological research, Semax is utilized primarily to investigate peptide-driven neuroprotection, central nervous system gene expression, and neurotrophic factor regulation. All batches produced for the PX1 research library undergo solid-phase peptide synthesis (SPPS) using strictly controlled coupling reagents to prevent racemization and ensure consistent sequence fidelity.
In vitro and animal models indicate that Semax exerts its neuro-active effects primarily through the upregulation of brain-derived neurotrophic factor (BDNF) and its cognate receptor, tropomyosin receptor kinase B (TrkB). Preclinical studies suggest that exposure to Semax results in a rapid increase in BDNF mRNA transcription within hippocampal and cortical neuronal cultures, fostering an environment optimized for studying synaptic plasticity.
Furthermore, research models demonstrate that Semax influences the expression of neurotrophin-3 (NT-3) and nerve growth factor (NGF). By stimulating neurotrophin synthesis, the heptapeptide provides a molecular framework for investigating neuronal survival under hypoxic, ischemic, or excitotoxic stress conditions. Experimental designs evaluating cell viability often measure downstream targets of the TrkB cascade, including the MAPK/ERK and PI3K/Akt pathways.
In addition to neurotrophic modulation, preclinical data suggest Semax interacts with the melanocortin receptor system. The peptide acts as a selective agonist at melanocortin MC4 and MC5 receptors without inducing adrenal steroidogenesis. This unique pharmacological profile allows researchers investigating research peptides to isolate central melanocortin signaling pathways from peripheral endocrine responses.
For academic institutions, biotechnology enterprises, and clinical research organizations, sourcing quality reagents is vital to reproducible data. Overseas peptide suppliers frequently rely on non-standardized batch synthesis, resulting in significant lot-to-lot variance, residual trifluoroacetic acid (TFA) contamination, heavy metal impurities, and high endotoxin levels that can invalidate cell culture assays.
PX1 Research addresses these critical supply chain risks by maintaining 100% domestic synthesis within USA-based, GMP-compliant facilities. By manufacturing our peptides domestically, PX1 eliminates international customs delays, cold-chain breakdowns, and unverified raw material sourcing. Every lot of Semax produced is subjected to comprehensive testing in an independent ISO 17025 accredited laboratory prior to release.
When purchasing agents evaluate suppliers to buy Semax, vendor reliability and assay safety are paramount. Overseas products often advertise high purity based on generic raw material certificates, whereas PX1 provides verifiable, lot-specific Certificates of Analysis (COA) confirming high analytical purity (>99%) and minimal endotoxin burden (<0.01 EU/mg).
Every unit of Semax distributed by PX1 Research is accompanied by a full-panel, lot-specific Certificate of Analysis. Analytical transparency requires dual-method validation: High-Performance Liquid Chromatography (HPLC) to measure chemical purity, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular identity.
Chromatographic purity is determined by reversing-phase HPLC (RP-HPLC), where the area under the curve (AUC) for the main Semax peak must exceed 99.0%. This confirms the absence of truncated sequences, deletion peptides, or residual protecting groups. Mass spectrometry confirms the monoisotopic mass of the target peptide, matching the theoretical mass of 813.92 Da with high resolution.
In addition to purity and mass verification, PX1 performs quantitative limulus amebocyte lysate (LAL) testing to establish endotoxin limits. Because bacterial endotoxins (lipopolysaccharides) alter cellular cytokine expression and induce inflammatory artifacts in cell-based assays, maintaining endotoxin levels below 0.01 EU/mg is essential for high-fidelity in vitro research.
Researchers evaluating neuro-active peptides often compare Semax against structurally or functionally related compounds within the same chemical class. The primary analog, Selank, is a synthetic heptapeptide derived from human tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) that targets GABAergic transmission and immune modulation rather than the melanocortin/BDNF pathway utilized by Semax.
Modified derivatives such as N-Acetyl Semax Amidate incorporate an N-terminal acetyl group and C-terminal amidation. In enzymatic degradation assays, these terminal caps resist exopeptidase cleavage, extending the peptide's functional half-life in extracellular matrix fluid beyond that of native Semax. Meanwhile, non-peptide synthetic compounds like Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) target similar neurotrophic pathways but differ fundamentally in molecular weight, receptor binding kinetics, and metabolic breakdown.
The following matrix summarizes key structural and operational parameters across these comparative research compounds:
• **Semax**: Met-Glu-His-Phe-Pro-Gly-Pro | MW: 813.92 g/mol | Primary Target: BDNF/TrkB, MC4/MC5 | Endotoxin Tested: <0.01 EU/mg | Synthesis: USA Solid-Phase
• **Selank**: Thr-Lys-Pro-Arg-Pro-Gly-Pro | MW: 751.90 g/mol | Primary Target: GABAergic system, Enkephalin degradation | Endotoxin Tested: <0.01 EU/mg | Synthesis: USA Solid-Phase
• **N-Acetyl Semax Amidate**: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2 | MW: 855.96 g/mol | Primary Target: BDNF/TrkB (Extended Half-Life) | Endotoxin Tested: <0.01 EU/mg | Synthesis: USA Solid-Phase
• **Noopept**: N-Phenylacetyl-L-prolylglycine ethyl ester | MW: 318.37 g/mol | Primary Target: AMPA/NDMA signaling, NGF expression | Endotoxin Tested: N/A (Small Molecule) | Synthesis: Chemical Synthesis
Semax is supplied as a lyophilized (freeze-dried) cake in sealed glass vials under inert argon gas atmosphere. Lyophilization preserves chemical stability during transit and ambient storage. Upon receipt in the laboratory, lyophilized Semax should be stored in a dry, dark environment at -20°C for long-term stability, or 2°C to 8°C for short-term storage.
Reconstitution protocols must follow standard aseptic laboratory techniques. For cell culture work, the peptide should be reconstituted using sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or sterile 0.9% Sodium Chloride solution. When reconstituting, direct the diluent down the glass wall of the vial rather than forcing liquid directly onto the lyophilized powder, gently swirling until dissolved. Avoid high-shear mechanical vortexing, which can disrupt peptide tertiary structure or induce aggregation.
Once reconstituted into solution, Semax aliquots should be divided into single-use experimental volumes to eliminate destructive freeze-thaw cycles. Reconstituted aqueous solutions stored at 2°C to 8°C remain stable for up to 30 days, while frozen aliquots stored at -80°C remain viable for extended analytical protocols.
In cell culture models, researchers utilize Semax across varying concentration ranges (typically 10 nM to 10 µM) to assess short-term signaling responses and long-term transcriptomic changes. In primary cortical neuron cultures, application of Semax is frequently used to quantify the kinetics of BDNF secretion into culture supernatants via ELISA assays.
Preclinical stroke and ischemia models evaluate Semax application in hypoxia-induced cell death assays. Investigators measure lactate dehydrogenase (LDH) release and caspase-3 cleavage to determine if Semax attenuates apoptotic signaling pathways under oxygen-glucose deprivation (OGD) conditions. Other cellular assays focus on inflammatory biomarkers, measuring changes in IL-6, TNF-alpha, and NF-kB activation following peptide treatment.
To ensure reproducible data across multi-well plate experiments, investigators should always reference the precise peptide content provided on the lot COA. Because lyophilized cakes contain trace moisture and counter-ions (such as acetate), calculating working concentrations based on absolute peptide purity rather than gross mass ensures precise dosing metrics.
Research timelines require reliable delivery schedules. PX1 Research operates dual fulfillment hubs in California and Arizona to guarantee rapid order dispatch across North America. Orders placed Monday through Friday before 3:00 PM EST ship the same day, minimizing transit exposure and preventing project downtime.
For academic departments, contract research organizations (CROs), and corporate research divisions requiring bulk material, PX1 provides streamlined workflow integration via our bulk institutional procurement account management system. We accommodate purchase orders, institutional credit terms, custom aliquot volumes, and bulk synthesis runs.
Whether procuring standard research units or establishing continuous supply lines for preclinical trials involving compounds like BPC-157 or Epithalon, PX1 maintains identical analytical standards: USA synthesis, full transparency, and lot-specific COA verification.
What is the certified chemical purity of PX1 Research Semax?
PX1 Research Semax is certified at >99.0% chemical purity as measured by High-Performance Liquid Chromatography (HPLC). Every batch includes a lot-specific Certificate of Analysis detailing HPLC purity and Mass Spectrometry mass identification.
How is endotoxin testing performed on Semax batches?
Endotoxin quantification is conducted via a quantitative Chromogenic Limulus Amebocyte Lysate (LAL) assay in an independent ISO 17025 accredited laboratory. All PX1 Semax lots must meet strict limits of <0.01 EU/mg prior to distribution.
Where is PX1 Semax synthesized and shipped from?
All Semax offered by PX1 Research is synthesized in USA-based, GMP-compliant facilities. Orders are fulfilled and shipped directly from our primary logistics centers located in California and Arizona.
What is the recommended storage temperature for lyophilized Semax?
Lyophilized Semax should be stored at -20°C for long-term storage (up to 24 months). For short-term laboratory storage prior to reconstitution, keeping the unopened vial at 2°C to 8°C in a dry, dark environment is acceptable.
What solvents should be used to reconstitute Semax for cell culture assays?
Semax is readily soluble in aqueous buffers. For in vitro cell culture and preclinical assays, standard laboratory diluents include sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or sterile 0.9% Sodium Chloride solution.
How does Semax differ structurally from N-Acetyl Semax Amidate?
Semax is the unmodified heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro). N-Acetyl Semax Amidate features N-terminal acetylation and C-terminal amidation, chemical modifications engineered to reduce enzymatic cleavage by exopeptidases in experimental media.
Can academic laboratories establish wholesale or institutional accounts with PX1?
Yes. PX1 Research offers dedicated support for academic, corporate, and CRO accounts. Purchasing departments can request institutional terms, custom packaging, and bulk pricing by applying through our wholesale portal.
Is PX1 Semax approved for clinical or human consumption?
No. Semax provided by PX1 Research is strictly sold as a research chemical compound for laboratory in vitro and preclinical experimentation only. It is not intended for human or animal medical, clinical, therapeutic, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.